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The extracellular serine protease, plasmin, is activated from its precursor, plasminogen (Plg), by the urokinase-type and tissue-type Plg
activators (uPA and tPA respectively). One of the main plasmin substrates, fibrin, is formed from fibrinogen via thrombin activity. We have
previously shown that mice deficient for Plg are strikingly less able to support a litter during lactation compared to wild type mice. Here we
suggest a mechanism responsible for this lactation defect. Reduced epithelial content and increased apoptosis are observed in Plg-deficient
mammary glands at lactation day 7. Immunofluorescence analysis reveals the presence of fibrin(ogen) in the stroma surrounding mammary alveoli
and adipocytes and identifies fibrin(ogen) as a component of breast milk in both wild type and Plg-deficient mice. Furthermore, a large
accumulation of fibrin(ogen) together with apoptotic epithelial cells is observed in the lactating mammary alveoli and ducts of some Plg-deficient
mice. This suggests that fibrin plays a key role in the malfunction of mammary glands in the absence of Plg, possibly through blockade of
mammary ducts inducing milk stasis, inhibiting milk expulsion and thereby inducing premature apoptosis and involution.
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The mammary gland of the mouse is a dynamic structure that
undergoes the majority of its development postnatally. During
puberty, the epithelial component of the gland expands through
a process of ductal elongation and branching morphogenesis
until it reaches the edge of the fat pad. Upon pregnancy, the
epithelium fills the fat pad further through proliferation. Hollow
alveoli lined with secretory epithelial cells are formed,
surrounded by contractile myoepithelial cells and a basement
membrane. Following parturition, milk is secreted by the
alveolar epithelial cells and flows down the mammary ducts to
the nipple to provide nutrition for suckling pups. Upon weaning,Abbreviations: BM, basement membrane; BrdU, 5-bromo-2-deoxy-uridine;
Fib, fibrinogen; ECM, extracellular matrix; MMP, matrix metalloprotease; PAI-
1, plasminogen activator inhibitor-1; Plg, plasminogen; TEBs, terminal end
buds; tPA, tissue plasminogen activator; uPA, urokinase plasminogen activator.
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doi:10.1016/j.ydbio.2006.07.021suckling ceases and the gland remodels back to a virgin-like
state. This process is termed involution and can be artificially
synchronised by removal of suckling pups mid-lactation.
Involution can be separated into three phases, a primary rever-
sible apoptotic phase during which differentiated secretory
epithelial cells die by apoptosis, a secondary irreversible remo-
delling phase comprising further apoptosis and extracellular
protease activity which remodels the extracellular matrix (ECM)
and a tertiary biosynthetic phase characterised by further ECM
remodelling and repopulation of the mammary gland by diffe-
rentiated adipocytes (Alexander et al., 2001; Green and Lund,
2005; Green and Streuli, 2004; Li et al., 1997; Lund et al.,
1996).
Plasmin is a serine protease involved in mammary gland
involution (Busso et al., 1989; Lund et al., 1996; Ossowski
et al., 1979) and is also active during other tissue remo-
delling events such as wound healing, trophoblast implanta-
tion and cancer invasion and metastasis (Almholt et al.,
2005; Bugge et al., 1998; Romer et al., 1996; Solberg et al.,
2003). It directly degrades matrix proteins such as fibrin and
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-9 and -13 (Dano et al., 2005; Lijnen, 2001; Liotta et al.,
1981). Plasmin is activated from its inactive zymogen pre-
cursor, Plg, through the serine protease urokinase-type (uPA)
and tissue-type (tPA) Plg activators (Castellino and Ploplis,
2005). These activate hepatically produced circulating Plg
at local sites around the body. Binding of uPA to its specific
receptor, uPAR, facilitates activation of Plg at the cell sur-
face and protects from the endogenous inhibitors plasmino-
gen activator inhibitor (PAI)-1 and α2-antiplasmin (Ploug,
2003).
During post-lactational involution, uPA expression is up-
regulated in the stromal cells surrounding alveoli and ducts
(Lund et al., 1996). Primiparous mice lacking Plg display
reduced alveolar regression and suppressed adipogenesis
during mammary gland involution and accumulate a fibrotic
stroma (Lund et al., 2000; Selvarajan et al., 2001).
Moreover, Plg is required for lactation since some Plg−/−
mice are unable to successfully support their first litter (Lund
et al., 2000). Furthermore, second pregnancies in Plg−/− mice
rarely result in healthy litters at the weaning stage due to
severe lactational dysfunction (Lund et al., 2000). In order
to elucidate the mechanism underlying this lactational inabi-
lity, we analysed the mammary glands of Plg+/+ and Plg−/−
mice during late pregnancy and the early stages of lactation.
We show that deposition of basement membrane and epi-
thelial differentiation occur normally in Plg−/− mice and that
a loss of epithelium due to premature apoptosis during
lactation coincides with accumulation of fibrin(ogen) and a
fibrin fragment. These changes suggest untimely involution,
which is likely responsible for the failed lactation in Plg−/−
mice.
Materials and methods
Animals and tissue treatment
Plg gene-targeted 129/Black Swiss mice (Bugge et al., 1995) were back-
crossed into C57BL/6J (Panum Institute, Copenhagen) for 21 generations.
Heterozygous mice were interbred to obtain an F1 generation of Plg+/+ and
Plg−/− siblings, which was used for experiments. Fibrinogen (Fib) gene-targeted
mice (Ploplis et al., 2000) were backcrossed into an FVB/n background (Panum
Institute, Copenhagen) for 8 generations. Heterozygous mice were crossed with
C57BL/6J heterozygous Plg mice to obtain an F1 generation of double
heterozygous Fib+/−;Plg+/− siblings. These double heterozygous mice were
crossed to obtain an F2 generation of siblings, which was used for experiments.
Mammary glands were collected during pregnancy at day 15.5 after vaginal
plug detection or during lactation. To normalise lactation pressure, the number
of pups for each dam was adjusted to seven on post-partum day 1 and
maintained at seven through the lactation period. This was carried out for all
experiments except that described in Fig. 1 where litter sizes were not altered.
Mammary glands were collected 2, 4 and 7 days after birth. All pregnant and
lactating mice studied were primiparous. For 5-bromo-2-deoxy-uridine (BrdU)
incorporation, day 15.5 pregnant and lactating day 2 mice were injected
intraperitoneally with 100 μg BrdU (Sigma, B-9285)/g body weight, 1 h prior
to killing. Isolation of milk from lactating mice was performed as described
previously (Schwertfeger et al., 2003). Briefly, suckling pups were removed
from lactating dams 4 h prior to milk isolation, after 4 h, mice were
anaesthetised (see below) and injected intraperitoneally with 5 IU units of
oxytocin (Sigma, O-4375) to induce milk let down. The milk was removed
from the mammary glands using suction.For isolation of tissue, mice were anaesthetised by intraperitoneal injection
of 0.03 ml/10 g of a 1:1 mixture of Dormicum (Midazolam 5 mg/ml) and
Hypnorm (Fluanison 5 mg/ml and Fentanyl 0.1 mg/ml). The mice were perfused
intracardially with 10 ml of ice-cold phosphate-buffered saline (PBS) and the
left abdominal mammary gland #4 or both #5 mammary glands removed,
weighed and snap frozen in liquid nitrogen for protein/DNA extraction or
prepared for whole mount analysis as previously described (Sympson et al.,
1994). The mice were then perfused intracardially with 10 ml 4% (w/v)
paraformaldehyde (PFA) and the right abdominal mammary gland #4 removed,
weighed and fixed for 16 h in 4% PFA. The tissue was then stored in 70%
ethanol, rinsed in PBS, dehydrated and embedded in paraffin.
Animal care at the University of Copenhagen and Copenhagen University
Hospital, Copenhagen, Denmark was in accordance with national and
institutional guidelines, and all mice were found to be free of murine pathogens
in accordance with the FELASSA recommendations for health monitoring of
experimental units (Rehbinder et al., 1996).
Stereological analysis
Mammary glands were isolated, fixed and embedded in paraffin wax as
described above. The paraffin-embedded glands were all cut diagonally to the
long axis of the mammary gland into 2 mm-thick parallel slabs resulting in 5–7
slabs per mammary gland. The first cut was positioned within 2 mm of the most
distal part of the gland. The slabs were then placed with identical orientation into
a metal capsule and re-embedded in paraffin wax. Four micrometer-thick
paraffin sections obtained from these blocks, thus containing representative
tissue with 2 mm distance throughout the mammary gland, were H&E-stained
for stereological analyses using CAST-grid stereology software (Olympus). For
counting of the number of apoptotic cells, BrdU-stained cells or epithelial cells,
a counting frame of 0.016 mm2, was applied to at least 150 fields of view
containing mammary tissue at ×1300 magnification. All events within this
counting frame were counted, and the total number of events per total area was
multiplied with the mammary tissue area (see below) to yield an unbiased
relative number of events per tissue section (representing individual mammary
glands). To obtain estimates of the total mammary tissue area, point counting
was carried out. 150 points or more were counted per slide (each point
measuring 0.1–0.4 mm2). All observations were made blind to the genotype of
the analysed samples.
Statistical analysis
Student's t test was carried out for the majority of the comparisons with
P values equal to or less than 0.05 considered significant.
Immunohistochemical analysis
H&E staining
Tissue sections were floated onto SuperFrost+ slides (Fisher Scientific,
Pittsburgh, PA, USA), deparaffinised in xylene, hydrated through graded
ethanol/water dilutions, stained with Mayer's haematoxylin and eosin then
dehydrated through graded ethanol/water solutions and mounted in Pertex
(Sakura Prohosp, Værløse, Denmark).
BrdU staining
Tissue sections from BrdU-injected mice were deparaffinised in xylene and
hydrated through graded ethanol/water dilutions. Antigen retrieval was by
microwaving at 98°C for 15 min in citrate buffer (10 mM, pH 6). This
treatment also prevents recognition of endogenous IgG by anti-mouse
antibodies. Endogenous peroxidase activity was blocked using 1% hydrogen
peroxide for 15 min at ambient temperature. Sections were then washed in
running tap water for 3–5 min and Tris-buffered saline (TBS: 50 mM Tris,
150 mM NaCl, pH 7.6) containing 0.5% Triton X-100 (TBS-T) for 5 min. The
slides were then mounted into Shandon racks with immunostaining coverplates
(AX-LAB, Copenhagen, Denmark) for subsequent incubations. Slides were
incubated overnight with mouse anti-BrdU antibody (1:600, DAKO, Glostrup,
Denmark, M-0744) at 4°C. All antibody incubations were followed by washes
in TBS-T. Mouse anti-BrdU antibody was detected with EnVision+® anti-
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temperature and visualised with VECTOR NovaRED™ substrate kit for HRP
(Vector, California, USA, SK-4800). Slides were counterstained in Mayer's
haematoxylin, dehydrated through graded ethanol/water solutions and mounted
in Pertex. Negative controls were prepared in parallel both without primary
antibody and substituting primary antibody with mouse IgG1 (DAKO, X-0931). Skin and intestine from BrdU-injected mice were used as positive
controls.
Laminin and collagen IV antibodies
Tissue sections were deparaffinised in xylene and hydrated through
graded ethanol/water dilutions. Antigen retrieval was by incubation with
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by pepsin treatment (4 mg/ml in 0.01 M HCl, 1 h, 37°C) for collagen IV
antibody. The slides were then placed in an Optimax Plus Immunostainer
(Biogenex) for subsequent incubations at room temperature. Endogenous
peroxidase activity was blocked using 1% hydrogen peroxide for 15 min.
Slides were incubated with anti-laminin antibody (Klinowska et al., 1999)
(1:1000 in Dako diluent, S-3022) or anti-collagen IV antibody (Research
Diagnostics, Inc, RDI-PR010760, 1:100 in Dako diluent) for 30 min. All
antibody incubations were followed by washes in TBS-T. Both antibodies
were detected with EnVision+® anti-rabbit HRP-linked secondary antibody
(DAKO, K-4003) for 30 min and visualised with VECTOR NovaRED™
substrate kit for HRP. Slides were counterstained in Mayer's haematoxylin,
dehydrated through graded ethanol/water solutions and mounted in Pertex.
Negative controls were prepared in parallel without primary antibody.
Double immunofluorescence
Tissue sections were deparaffinised in xylene and hydrated through graded
ethanol/water dilutions. Antigen retrieval was by incubation with proteinase K
for 15 min at 37°C. Sections were then washed in running tap water for 5 min and
Tris-buffered saline (TBS: 50 mM Tris, 150 mM NaCl, pH 7.6) for 5 min. The
slides were then mounted with TBS-T in Shandon racks with immunostaining
coverplates (AX-LAB, Copenhagen, Denmark) for subsequent incubations.
Sections were incubated overnight with both rabbit anti-mouse fibrin(ogen)
antibody (1:2000, (Bugge et al., 1995)) and rat anti-mouse Troma1 antibody
(detects cytokeratin 8, 1:100, (Kemler et al., 1981)) simultaneously, in TBS
containing 0.25% bovine serum albumin (BSA) at 4°C. Rabbit anti-fibrin(ogen)
antibody was detected with Alexa Fluor 488-linked donkey anti-rabbit antibody
(1:200, Molecular Probes, California, USA, A21206) and rat anti-Troma1
antibodywas detected with Alexa Fluor 594-linked goat anti-rat antibody (1:200,
Molecular Probes, A11007) diluted together in TBS containing 0.25% bovine
serum albumin (BSA) and incubated for 45 min at ambient temperature.
Antibody incubations were followed by washes in TBS. Slides were counter-
stained with Hoechst 33342 (1:5000, Molecular Probes, H3570) in TBS for
10 min at ambient temperature and mounted in fluorescent mounting medium
(DAKO, S3023). Negative controls without anti-fibrin(ogen) primary antibody
were negative for unspecific staining.
Western blot analysis
Mammary gland pieces were ground in liquid nitrogen with a pestle and
mortar then homogenised in RIPA lysis buffer (150 mM NaCl, 50 mM Tris·Cl
pH 7.4, 5 mM EDTA, 1% NP-40, 1% DOC, 0.1% SDS) at 10 μl/mg of tissue,
and homogenates were centrifuged at 16,000×g for 20 min at 4°C. Soluble
fractions were stored at −80°C. To visualise proteins, RIPA-soluble lysates were
resolved on SDS-PAGE mini-gels and transferred to PVDF membranes.
Membranes were blocked for 1 h at ambient temperature with 5% non-fat dried
milk (or BSA for β-casein blots) in phosphate-buffered saline (PBS: 136 mM
NaCl, 3.3 mM KCl, 10 mM Na2HPO4, pH 7.4) containing 0.05% Tween-20
(PBS-T) and incubated overnight at 4°C with 0.5 μg/ml rabbit anti-mouse fibrin
(ogen) antibody (Innovative Research Inc, Michigan, USA), 1 μl/ml rabbit anti-
human fibrin(ogen) antibody (DAKO, A0080) or 1 μl/10 ml mouse anti-β-
casein (Kaetzel and Ray, 1984) in blocking buffer. After washing in PBS-T
(5×5 min), membranes were incubated for 1.5 h at ambient temperature with
anti-rabbit or anti-mouse horseradish peroxidase (HRP)-linked secondaryFig. 1. Plg-deficient mice are poor mothers and have mammary glands with a reduced
Plg−/− female mice were mated with Plg−/− or Plg+/+ male mice respectively to pro
parturition. Their litters were weighed daily and the survival of the progeny monitor
lactation. (b) A graph showing the percentage of pups surviving during the time sca
gland #4 from Plg+/+ and Plg−/−mice was examined during late pregnancy and lactatio
Plg−/− mice at pregnancy day 15.5 (P15.5) and lactation days 2, 4 and 7 (L2, L4, L7)
arrows label the functioning hollow alveoli, lined with secretory epithelial cells, of th
cells per section determined using an unbiased stereological counting technique to com
and Plg−/−mice at P15.5 and L2, L4 and L7. Note that the number of epithelial cells p
that at L7, the epithelial content of the Plg−/− glands is markedly reduced compared w
mammary gland of one mouse. Bars=mean value for groups. (e) Higher magnificatio
Plg+/+ and Plg−/− mice at L7 to illustrate the influx of inflammatory cells observed in
label two apoptotic epithelial cells in another alveolus (scale bar=25 μm).antibody (DAKO, P0217) diluted 1:5000 in blocking buffer. Membranes were
washed again in PBS-T prior to detection of HRP activity using enhanced
chemiluminescence (ECL) reagents (Amersham Biosciences, Hillerød, Den-
mark). A negative control without primary antibody included was carried out in
parallel.Results
Plg-deficient mice lactate poorly and display decreased
mammary epithelial content during lactation
Previously, we reported that a significant number of Plg−/−
mice backcrossed into a C57BL/6J background fail to lactate
successfully (Lund et al., 2000). To further investigate this, the
fate of Plg+/− pups born to either Plg+/+ or Plg−/− primiparous
mothers was monitored for 17 days following birth (Fig. 1). The
average total litter weight of Plg+/+ mothers increased during the
observation period in contrast to that for Plg−/− mothers (Fig.
1a). In addition, the average number of pups surviving after
3 days post-partum remained constant for those pups born to
Plg+/+ mothers, whereas litters born to Plg−/− mothers died
gradually over the 17-day observation period (Fig. 1b). In fact,
three quarters of the Plg−/− mice displayed failed lactation as
measured by pup death during the 17-day period monitored.
Mammary glands from Plg+/+ mice increase in weight during
lactation whereas those from Plg−/− mice do not ((Lund et al.,
2000) and data not shown). To determine the reason for this, we
analysed the histology of mammary glands from Plg+/+ and
Plg−/− mice at pregnancy day 15.5 (P15.5) and lactation days 2,
4 and 7 (L2, L4 and L7). Analysis of haematoxylin and eosin
(H&E)-stained tissue sections revealed no obvious histological
differences in secretory epithelium, adipose tissue and con-
nective tissue between Plg+/+ and Plg−/− mice at P15.5 and L2
(Fig. 1c). In contrast, a clear regression of the secretory
epithelium was observed in all Plg−/− glands at L4 and L7 (Fig.
1c). This was accompanied by abundant apoptosis in many
Plg−/− glands (see below). Morphometric analysis of mammary
gland tissue at P15.5, L2, L4 and L7 revealed that the number of
epithelial cells in the mammary gland sections of Plg+/+ mice
was higher than that in the Plg−/− glands, particularly at L7
(p=0.000002, Student's t test), when the average epithelial
compartment of the Plg+/+ mammary glands was approximately
double that of the Plg−/− glands (Fig. 1d). An influx of
inflammatory cells was also observed in some Plg−/− glands at
L7 (Fig. 1e). These results clearly demonstrate that there is asecretory epithelium during lactation compared with wild type glands. Plg+/+ and
duce litters heterozygous for Plg. Ten Plg+/+ and eight Plg−/− mothers reached
ed for 17 days. (a) A graph showing the average litter weight per mouse during
le monitored. *p<0.05, **p<0.005 in Student's t test. Histology of mammary
n. (c) Haematoxylin and eosin-stained mammary gland sections from Plg+/+ and
(scale bar=200 μm). Open double-ended arrow labels a mammary duct. Closed
e lactating gland. Open arrows label regressing alveoli. (d) Number of epithelial
pare the number of mammary epithelial cells in the #4 mammary gland of Plg+/+
er section is similar in Plg+/+ glands and Plg−/− glands during late pregnancy, but
ith the wild type glands. Each data point represents the measurement from the #4
n photographs of haematoxylin and eosin-stained mammary gland sections from
some Plg−/− glands. A group of inflammatory cells is encircled. Closed arrows
168 K.A. Green et al. / Developmental Biology 299 (2006) 164–175gradual and severe loss of secretory epithelial cells in the
mammary glands of Plg−/− mice through the earlier stages of
lactation.
Basement membrane deposition and differentiation of the
secretory epithelium are not affected by Plg deficiency
We carried out immunohistochemistry for key components
of the basement membrane (BM) on mammary gland
sections from Plg+/+ and Plg−/− mice at pregnancy dayFig. 2. Basement membrane deposition and mammary epithelial cell differentiati
Immunohistochemistry for laminin I and collagen IVon mammary gland sections fro
(scale bar=25 μm). No differences in basement membrane deposition as visualised b
and Plg−/− mammary glands. (b) Equal amounts of pooled RIPA-derived protein
electrophoresed by reducing 12% SDS-PAGE and immunoblotted with an anti-β-cas
positive control of mouse milk was also included on the gel, and a lysate from a wi
secondary antibody alone (data not shown).15.5 (P15.5) and lactation day 2 (L2) to determine if any
differences in BM deposition were present due to the lack of
plasmin activity. Analysis of the sections revealed no
obvious differences in the localisation of the BM compo-
nents laminin I and collagen IV between Plg+/+ and Plg−/−
mammary glands (Fig. 2a). We also examined mammary
tissue for evidence of differentiation by western blotting
tissue lysates for the milk protein β-casein (Fig. 2b). This is
produced by the secretory epithelium during late pregnancy
and lactation and demonstrates functional mammary luminalon in wild type and Plg-deficient glands during pregnancy and lactation. (a)
m Plg+/+ and Plg−/− mice at pregnancy day 15.5 (P15.5) and lactation day 2 (L2)
y laminin and collagen IV immunohistochemistry were observed between Plg+/+
lysates from Plg+/+ and Plg−/− mammary glands at P15.5, L2 and L7 were
ein antibody. Pooled lysates contained equal amounts of protein from 3 mice. A
ld type virgin gland served as a negative control. No bands were observed with
169K.A. Green et al. / Developmental Biology 299 (2006) 164–175epithelial cell differentiation, which is also dependent upon
the presence of an intact BM (Streuli et al., 1991). Thus, BM
deposition and milk protein production in the mammary
gland during late pregnancy and early lactation are
unaffected by a lack of Plg.
Rates of proliferation and apoptosis in lactating mammary
glands from wild type and Plg-deficient mice
We next examined if the reduced number of epithelial cells
in the glands of Plg−/− mice was due to a diminished level ofFig. 3. Epithelial cell proliferation and apoptosis in wild type and Plg-deficient gla
intraperitoneally with 5-bromo-2-deoxy-uridine (BrdU) (100 μg/g of mouse) at preg
gland #4 from these mice was examined using an unbiased stereological counting te
per gland during late pregnancy and lactation. Each data point represents the measu
of mammary glands from BrdU-injected mice at P15.5 are shown with BrdU-incorp
Plg+/+ and Plg−/− mice was examined using an unbiased stereological counting tec
cells were recognised by apoptotic morphology in haematoxylin and eosin-stained
compared to Plg+/+ at L4 and L7. Each data point represents the measurement
Representative photographs of haematoxylin and eosin-stained mammary tissue sect
(scale bar=25 μm).epithelial cell proliferation in these glands. The extent of
epithelial cell proliferation was determined by BrdU injection
in vivo followed by immunohistochemical detection of BrdU-
positive cells in Plg+/+ and Plg−/− glands at P15.5 and L2 using
stereology-based morphometry (Nielsen et al., 2001). A modest
but statistically significant decrease (p=0.04, Student's t test)
in epithelial proliferation levels was detected in the Plg−/−
glands at P15.5 compared to Plg+/+ glands, whereas at L2, there
was no difference in proliferation levels between the two
genotypes (Fig. 3a). Proliferation levels at L4 and L7 were not
analysed since at these stages the majority of epithelialnds during pregnancy and lactation. (a) Plg+/+ and Plg−/− mice were injected
nancy day 15.5 (P15.5) or lactation day 2 (L2), 1 h prior to sacrifice. Mammary
chnique to measure the number of epithelial cells positively staining for BrdU
rement from the #4 mammary gland of one mouse. Representative photographs
orated nuclei staining brown (scale bar=25 μm). (b) Mammary gland #4 from
hnique to measure apoptosis levels during pregnancy and lactation. Apoptotic
tissue sections. Increased apoptosis levels were observed in the Plg−/− glands
from the #4 mammary gland of one mouse. Bars=mean value for groups.
ions at L7 are shown with closed arrows labelling two apoptotic epithelial cells
Fig. 4. Fibrin fragments accumulate in Plg-deficient glands during lactation. (a) RIPA-derived protein lysates from Plg+/+ and Plg−/−mammary glands at P15.5, L4 and
L7 were electrophoresed by non-reducing 8% SDS-PAGE and immunoblotted with an anti-mouse fibrinogen polyclonal antibody that recognises both fibrinogen and
fibrin. A positive control of mouse fibrinogen was also included on the gel (*). No bands were observed with secondary antibody alone (data not shown). (b) Tissue
sections from Plg+/+ and Plg−/−mammary glands at P15.5, L2, L4 and L7 were stained for double immunofluorescence with antibodies to cytokeratin 8 (red) and fibrin
(ogen) (green) accompanied by nuclear staining with Hoechst (blue). At L7, in some Plg−/− glands, a large influx of inflammatory cells into the gland is observed (see
inset in L7, Plg−/−), these can be recognised since their nuclei stain blue but the cells do not stain for cytokeratin 8 (red). Scale bar=100 μm. (c) Tissue sections were
stained as in panel b. Fibrin(ogen) can be seen accumulating in the alveoli of both Plg+/+ and Plg−/− mammary glands (see inset in L2, Plg+/+), however, in Plg−/−
glands, large amounts of fibrin can be seen in some distended alveoli, and this is often accompanied by an accumulation of apoptotic epithelial cells (white arrows in
Plg−/− L2 and L4). Scale bar=100 μm. (d) Photographs of serial mammary gland sections from a Plg−/− mouse at L10 to demonstrate the blockage (closed arrow) of
mammary ducts in Plg−/− glands with fibrin(ogen). One section was stained with haematoxylin and eosin, and the next was stained for double immunofluorescence
with antibodies to cytokeratin 8 (red) and fibrin(ogen) (green) accompanied by nuclear staining with Hoechst (blue). Scale bar=200 μm. (e) Human and wild type
mouse milk were electrophoresed by non-reducing 8% SDS-PAGE and immunoblotted with an anti-human fibrinogen antibody which recognises both human and
mouse fibrinogen and fibrin. No bands were observed with secondary antibody alone (data not shown).
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1987). We have previously observed a transient but significant
delay in development of the ductal tree during puberty in Plg−/−
mice although Plg+/+ and Plg−/− mammary glands are both fully
developed by the end of puberty (data not shown). Develop-
ment of a lactation-proficient gland during pregnancy may also
be slightly delayed in Plg−/− mice, and this may account for the
reduced proliferation observed at P15.5 but not at L2. We next
examined if the decreasing numbers of epithelial cells in Plg−/−
glands during lactation were due to increased cell death.
Apoptotic cells were recognised by their morphology in H&E-
stained tissue sections, and apoptosis levels in mammary glands
were quantified according to stereological principles (Fig. 3b).
This analysis revealed that Plg deficiency is associated with
increased apoptosis during lactation that is statistically
significant (p=0.04, Student's t test) at L7. Over half the
Plg−/− mammary glands analysed at L7 contained abnormally
high numbers of apoptotic cells. The observed death of litters
born to Plg−/− mice thus coincides with reduced mammary
epithelial content due to a slightly reduced proliferation rate
during pregnancy and loss of secretory epithelial cells caused
by unscheduled apoptosis during lactation in Plg−/− mouse
mammary glands.Fig. 5. Analysis of lactation in Plg-deficient and fibrinogen heterozygous glands. (a)
glands at L7 were stained for double immunofluorescence with antibodies to cyto
Hoechst (blue). Scale bar=100 μm. (b) A graph comparing the epithelial content of L
of Fib+/+;Plg+/+, Fib+/+;Plg−/− and Fib+/−;Plg−/− mice. Bars=mean value for groups. E
mouse. (c) Pooled RIPA-derived protein lysates from #4 mammary glands at lactation
from Fig. 4 (lanes 1 and 2) by non-reducing 8% SDS-PAGE and immunoblotted with
and fibrin. A fibrin fragment 120–140 kDa in size was observed in the Fib+/+;Plg−
Pooled lysates contained equal amounts of protein from 3 mice.Fibrin fragments accumulate in the lactating mammary glands
of Plg-deficient mice
The above data suggest that the mammary glands of Plg−/−
mice lose epithelia during lactation due to unscheduled
apoptosis. It is known that the correct extracellular environment
is essential for the survival of mammary epithelial cells and for
lactogenesis (Boudreau et al., 1995; Pullan et al., 1996; Streuli
et al., 1995). Previously, it was reported that there is no apparent
abnormal accumulation of fibrin(ogen) in the mammary glands
of Plg−/− mice compared to wild type as detected by
immunohistochemistry using immunoperoxidase (Lund et al.,
2000). However, protein blotting with an anti-fibrinogen anti-
body revealed that a fibrin degradation product of 120–140 kDa
in size accumulates in 5 out of 6 mammary glands of Plg−/−
mice at L4 and L7 (Fig. 4a). Less is observed in the mammary
glands of their Plg+/+ littermates. This result suggests a
requirement for plasmin to further cleave fibrin that was
degraded to the size observed in immunoblots by the action of
other proteases.
Thus, we next used double immunofluorescent staining of
tissue sections for fibrin(ogen) (green) and cytokeratin 8 (red,
labels epithelial cells) accompanied by Hoechst staining of theTissue sections from Fib+/+;Plg+/+, Fib+/+;Plg−/− and Fib+/−;Plg−/− #4 mammary
keratin 8 (red) and fibrin(ogen) (green) accompanied by nuclear staining with
7 mammary glands as measured by an unbiased stereological counting technique
ach data point represents the measurement from the #4 mammary gland of one
days 4 and 7 were electrophoresed (lanes 3, 4 and 5) alongside the pooled lysates
an anti-mouse fibrinogen polyclonal antibody which recognises both fibrinogen
/− glands and reduced amounts of this accumulated in the Fib+/−;Plg−/− glands.
172 K.A. Green et al. / Developmental Biology 299 (2006) 164–175nuclei (blue) to analyse fibrin(ogen) localisation in the
mammary gland. Fibrin(ogen) is a component of the stroma
surrounding the mammary alveoli and differentiated adipocytes
(Fig. 4b, Plg+/+ P15.5 panel). We observed an accumulation of
fibrin strands in the lumens of lactating alveoli of wild type
glands (Fig. 4c, Plg+/+ L2 panel). However, in Plg−/− glands,
some alveoli contained a very large amount of fibrin and mixed
within this fibrin were apoptosing epithelial cells (Fig. 4c,
Plg−/− L4 panel). In addition, some Plg−/− glands were very
disorganised at L7 and contained a large influx of inflammatory
cells (Fig. 4b, Plg−/− L7 panel). Importantly, H&E staining of
Plg+/+ and Plg−/− glands revealed occasional physical ductal
blockages and dilation of mammary ducts in Plg−/− glands at
L10 (Fig. 4d and data not shown). When serial sections were
analysed with immunofluorescence, results showed that the
blockage was recognised with an anti-fibrin(ogen) antibody,
demonstrating that the material causing or contributing to this
blockage is fibrin(ogen) (Fig. 4d). The observation of fibrin
(ogen) as a component of breast milk was confirmed by the
detection of fibrin(ogen) in mouse and human milk by
immunoblotting (Fig. 4e). Unfortunately, the fibrin content of
milk from Plg−/− mice was not examined as it was extremely
difficult to obtain milk from these mice. This result demon-
strates for the first time that fibrin(ogen) is present in breast milk
and shows that an abnormal accumulation of fibrin(ogen)
occurs in the mammary alveoli and ducts of some Plg−/− mice
and appears to participate in the physical obstruction of
mammary ducts in Plg−/− glands.
Lactation in Plg-deficient and fibrinogen heterozygous
mammary glands
In order to directly test if the observed fibrin(ogen)
accumulation can account for the epithelial loss and lactation
phenotype in Plg−/− mice, we next examined mammary glands
from lactating mice deficient for Plg and heterozygous for
fibrinogen (Fib+/−;Plg−/−). Mice deficient for fibrinogen die
during pregnancy and therefore could not be used for the
experiment (Iwaki et al., 2002; Suh et al., 1995). We found that
mice heterozygous with respect to fibrinogen and deficient for
Plg were able to complete a full pregnancy, give birth and
lactate without problem (data not shown). Thus, we examined
day 7 lactating mammary glands from Fib+/+;Plg+/+, Fib+/+;
Plg−/− and Fib+/−;Plg−/− mice (Fig. 5). The average number of
epithelial cells in Fib+/−;Plg−/− mammary glands was slightly
increased compared with Fib+/+;Plg−/− glands, although the
difference was not statistically significant (Figs. 5a and b).
The accumulation of the fibrin degradation fragment
observed in the pooled lysates of mammary glands of Fib+/+;
Plg−/− mice by immunoblotting was reduced in pooled lysates
(n=3) from the mammary glands of the Fib+/−;Plg−/− mice (Fig.
5c). However, total levels of fibrinogen did not appear to differ
greatly between Fib+/+ and Fib+/− mammary glands when
analysed by immunoblotting, indicating that Fib+/− mice are
still able to produce wild type levels of fibrinogen and do not
exhibit a heterozygous phenotype in this respect. Based on these
results with fibrin(ogen) heterozygous mice, we cannot directlyshow that simultaneous lack of fibrin(ogen) and Plg affects the
phenotype observed in lactating Plg−/− mice.
Discussion
In this report, we describe and offer an explanation for a loss of
function phenotype observed in Plg−/− mouse mammary glands
during lactation. This phenotype arises owing to a significant
reduction in mammary epithelial content observed mid-lactation
(L4 and L7) due to increased apoptosis levels in Plg−/− glands
compared to Plg+/+, and this correlates with accumulation of a
fibrin degradation fragment in the mammary glands and a
resultant significant loss of litters following day 7 of lactation.
Fibrin fragment accumulation
Our results suggest that the accumulation of fibrin(ogen) and
fibrin fragments in Plg−/− mammary glands during lactation
may actually induce premature involution. This may be through
one of three or more mechanisms. (1) The dependence of
mammary epithelial cells on the correct basement membrane
and ECM for survival is well-established (Boudreau et al.,
1995; Pullan et al., 1996; Streuli et al., 1991, 1995). Alteration
of this substratum could be the reason for premature apoptosis
and loss of epithelium in lactating glands. (2) Some ECM
degradation products have an inherent signalling ability, and
this has been shown in the mammary gland previously. A
laminin 5 fragment released through MMP-dependent cleavage
and also during mammary gland involution is able to bind to the
EGF receptor and initiate downstream signalling (Schenk et al.,
2003). In our situation, the degradation of fibrin may occur
during pregnancy and lactation to allow expansion of the
mammary epithelium in preparation for milk production. Other
extracellular proteases may be able to degrade fibrin to the size
of the fragment we observe, whereas further degradation
requires plasmin. This could lead to induction of apoptosis
through binding of the fragment to a receptor on the epithelial
cells. (3) Fibrin(ogen) (demonstrated in this report) and Plg
(Greenberg and Groves, 1984; Heegaard et al., 1997) are both
present in breast milk. The lack of Plg in the milk of Plg−/− mice
may result in the formation of fibrin clots during lactation,
blocking mammary ducts and inducing premature involution
through milk stasis (Li et al., 1997; Talhouk et al., 1991).
In our opinion, this third theory for the premature involution
phenotype is the most likely for the following reasons. We
demonstrate for the first time the presence of fibrin(ogen)
strands in the lactating alveoli of the wild type mammary gland
and show by western blotting that fibrinogen is a component of
human and mouse breast milk. However, we can only speculate
as to the function of the fibrin(ogen) we observe. Milk is heavily
loaded with blood proteins such as antibodies and therefore
maybe fibrin(ogen) is present due to this. Otherwise, it could be
involved in the postnatal differentiation and maturation of the
gastrointestinal tract, which occurs during the first 2 weeks after
birth. It has been known for some time that Plg is a component
of milk (Greenberg and Groves, 1984; Heegaard et al., 1997).
Plg has previously been hypothesised to serve two functions in
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tenance of patency and fluidity in the ducts of the mammary
gland (Heegaard et al., 1997). Our results with western blots of
fibrin fragments seem to indicate a requirement for plasmin to
remove lower molecular weight fibrin degradation products,
whereas it is likely that other proteases can compensate for
plasmin and degrade fibrin to the size of fragment observed.
One of the major mechanisms for involution induction is
thought to be milk accumulation and stasis. Fibrin accumulation
could block the mammary ducts and nipples, inducing milk
stasis and mammary gland involution through the activation of,
for example, stretch receptors during lactation. We note a large
influx of inflammatory cells into the mammary alveoli of glands
that also contain large clots of fibrin indicating that these two
events may be linked. Therefore, Plg is most likely required in
the mammary gland during lactation to degrade any fibrin clots
that are formed in milk, without it, large clots of fibrin
accumulate inducing ductal blockage, milk stasis and inhibition
of milk expulsion, inflammatory cell influx, secretory epithelial
cell apoptosis and thereby early involution.
Premature involution phenotype
Our results indicate that the involution delay in Plg−/− mice
described in our previous publication may actually be due to
premature but incomplete involution (Lund et al., 2000). We
conclude this since at lactation day 4 and especially at lactation
day 7 we observe increased apoptosis in the mammary glands of
Plg−/− mice. Experiments inducing involution in the mammary
gland of a mouse by teat sealing whilst allowing lactation to
progress as normal in the other glands have demonstrated that
the first apoptotic phase of mammary gland involution is
induced in sealed glands. However, alveolar structures are
preserved through an inhibition of induction of the second
remodelling phase of involution through systemic hormone
stimulation (Li et al., 1997; Talhouk et al., 1991). The above
theory suggesting that Plg−/− glands undergo premature
involution through blockage of the ductal system by fibrin
(ogen) accumulation also explains why the involution observed
in Plg−/− glands was initially thought to be delayed since the
alveolar structures are preserved (Lund et al., 2000). In addition,
this clarifies the variable nature of the phenotype, with some
Plg−/− glands displaying very high apoptosis levels at lactation
day 7 whilst others have virtually none. Fibrin accumulation
and ductal blockage will not occur at the same rate in every
mammary gland of a Plg−/− mouse. This will enable the
maintenance of suckling at some mammary glands on the
mouse, and thereby systemic hormone production, whilst others
are blocked by fibrin(ogen) and will exhibit a first phase of
involution phenotype like the one observed with teat sealing.
We noted that the mammary glands of Fib+/+;Plg+/+ mice in
Fig. 1d contained a higher epithelial content at L7 compared to
those in Fig. 5b. The mice in Fig. 1d are on a C57BL/6J
background, whereas the mice in Fig. 5b were on a mixed
C57BL/6J;FVB/n background. This explains the differing
epithelial content in the mouse mammary glands and empha-
sises the importance of mouse background strain for phenotypepenetrance. Despite this difference, the epithelial content of the
Plg−/− mouse mammary glands at L7 was still significantly
lower than that in the Plg+/+ mouse mammary glands in Fig. 5b.
We suggest that the accumulation of a fibrin fragment during
lactation actually causes the epithelial loss phenotype and that
this would be reversed in Fib−/−;Plg−/− glands, although our
results with Fib+/−;Plg−/− glands were not conclusive. Such a
reversal would not be entirely surprising since it has previously
been reported that combining Plg and fibrinogen deficiency
reverses a weight loss phenotype seen in older Plg−/− mice,
improves their life expectancy and reverses the delayed wound
healing phenotype of Plg−/− mice (Bugge et al., 1996). We were
not able to test this hypothesis since Fib−/− mothers die mid-
gestation (Suh et al., 1995). Further studies would be required to
confirm whether the prime function of Plg in the mammary
gland during lactation is that of fibrin degradation.
Plasminogen in the mammary gland
A previous report suggested that Plg was not required in the
mammary gland during lactation since low mRNA and activity
levels of the Plg activators, uPA and tPA were detected during
lactation compared to higher levels in the virgin gland, during
early pregnancy and in the latter stages of involution (Busso et
al., 1989). Our results do not necessarily contradict this report
since the build-up of fibrin that we observe may well occur
gradually through pregnancy and lactation and may normally
only require very low levels of Plg activation to clear. Rather,
what our results do show is that Plg activity, however little, is
important to maintain a correctly functioning mammary gland
during pregnancy and lactation. In this respect, it is noteworthy
that a number of MMPs have fibrinolytic activity (MMP-3, -8,
-9, -12, -13 and -14), and yet although some of these MMPs are
expressed in the mammary gland (reviewed in Green and Lund,
2005), the lactation phenotype observed in Plg−/− mice indicates
that there is not sufficient compensatory fibrinolytic activity from
other proteases. Furthermore, a third plasminogen activator, in
addition to uPA and tPA, plasma kallikrein, has recently been
described in adipocyte differentiation (Selvarajan et al., 2001)
and in wound healing (Lund et al., 2006). A role for plasma
kallikrein as a plasminogen activator during mammary develop-
ment, pregnancy and lactation still remains to be elucidated.
The inability of Plg−/− mice to support a litter has been
known for some time now. Based upon the results presented in
this report, we demonstrate that this is accompanied by
secretory cell loss through apoptosis and premature involution
and suggest a mechanism involving an accumulation of fibrin
fragments causing ductal occlusion, inhibition of milk expul-
sion and reduction of litter size.
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